Chimeric antigen receptor-engineered natural killer cells for cancer immunotherapy
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1756-8722
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Chimeric antigen receptor-engineered natural killer cells for cancer immunotherapy ; volume:13 ; number:1 ; day:7 ; month:12 ; year:2020 ; pages:1-22 ; date:12.2020
Journal of hematology & oncology ; 13, Heft 1 (7.12.2020), 1-22, 12.2020
- Creator
-
Yilmaz, Ahmet
Cui, Hanwei
Caligiuri, Michael A.
Yu, Jianhua
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s13045-020-00998-9
- URN
-
urn:nbn:de:101:1-2021011518085418608437
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
09.10.2025, 10:38 PM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Yilmaz, Ahmet
- Cui, Hanwei
- Caligiuri, Michael A.
- Yu, Jianhua
- SpringerLink (Online service)
Other Objects (12)
Chimeric antigen receptor engineered natural killer cells for cancer therapy
Purinergic targeting enhances immunotherapy of CD73+ solid tumors with piggyBac-engineered chimeric antigen receptor natural killer cells
Targeting CD5 chimeric antigen receptor-engineered natural killer cells against T-cell malignancies
A new insight in chimeric antigen receptor-engineered T cells for cancer immunotherapy
Chimeric antigen receptor-based natural killer cell immunotherapy in cancer: from bench to bedside
Chimeric antigen receptor-engineered NK cells: new weapons of cancer immunotherapy with great potential
Developing new chimeric antigen receptor (CAR)-engineered natural killer cells targeting ovarian cancer stem cells
Cancer-testis antigen specific chimeric antigen receptor T cells for cancer immunotherapy
CD19/CD20 dual-targeted chimeric antigen receptor-engineered natural killer cells exhibit improved cytotoxicity against acute lymphoblastic leukemia
Chimeric antigen receptor (CAR)-modified natural killer cell-based immunotherapy and immunological synapse formation in cancer and HIV
Cellular Immunotherapy for Hematological Disorders : From Allogeneic Stem Cell Transplantation to Chimeric Antigen Receptor-engineered T-cell Application
High cytotoxic efficiency of lentivirally and alpharetrovirally engineered CD19-specific chimeric antigen receptor natural killer cells against acute lymphoblastic leukemia
Chimeric antigen receptor engineered natural killer cells for cancer therapy
Purinergic targeting enhances immunotherapy of CD73+ solid tumors with piggyBac-engineered chimeric antigen receptor natural killer cells
Targeting CD5 chimeric antigen receptor-engineered natural killer cells against T-cell malignancies
A new insight in chimeric antigen receptor-engineered T cells for cancer immunotherapy
Chimeric antigen receptor-based natural killer cell immunotherapy in cancer: from bench to bedside
Chimeric antigen receptor-engineered NK cells: new weapons of cancer immunotherapy with great potential
Developing new chimeric antigen receptor (CAR)-engineered natural killer cells targeting ovarian cancer stem cells
Cancer-testis antigen specific chimeric antigen receptor T cells for cancer immunotherapy
CD19/CD20 dual-targeted chimeric antigen receptor-engineered natural killer cells exhibit improved cytotoxicity against acute lymphoblastic leukemia
Chimeric antigen receptor (CAR)-modified natural killer cell-based immunotherapy and immunological synapse formation in cancer and HIV
Cellular Immunotherapy for Hematological Disorders : From Allogeneic Stem Cell Transplantation to Chimeric Antigen Receptor-engineered T-cell Application
High cytotoxic efficiency of lentivirally and alpharetrovirally engineered CD19-specific chimeric antigen receptor natural killer cells against acute lymphoblastic leukemia
Chimeric antigen receptor engineered natural killer cells for cancer therapy
Purinergic targeting enhances immunotherapy of CD73+ solid tumors with piggyBac-engineered chimeric antigen receptor natural killer cells
Targeting CD5 chimeric antigen receptor-engineered natural killer cells against T-cell malignancies
A new insight in chimeric antigen receptor-engineered T cells for cancer immunotherapy
Chimeric antigen receptor-based natural killer cell immunotherapy in cancer: from bench to bedside
Chimeric antigen receptor-engineered NK cells: new weapons of cancer immunotherapy with great potential
Developing new chimeric antigen receptor (CAR)-engineered natural killer cells targeting ovarian cancer stem cells
Cancer-testis antigen specific chimeric antigen receptor T cells for cancer immunotherapy
CD19/CD20 dual-targeted chimeric antigen receptor-engineered natural killer cells exhibit improved cytotoxicity against acute lymphoblastic leukemia
Chimeric antigen receptor (CAR)-modified natural killer cell-based immunotherapy and immunological synapse formation in cancer and HIV
Cellular Immunotherapy for Hematological Disorders : From Allogeneic Stem Cell Transplantation to Chimeric Antigen Receptor-engineered T-cell Application